Loading OSCR…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("OSCR","financials")Full statements spill as a table. For one cell: =jivedata("OSCR","Revenue") or =jivedata("OSCR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
OSCR • CIK 0001568651
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Premiums Earned, Net | $5,686,069 | $8,971,259 | $11,469,893 | $15,040,821 |
| Revenue from Contract with Customer, Excluding Assessed Tax | $15,442 | $20,576 | $28,593 | $29,579 |
| Operating Income (Loss) | $-235,615 | $57,265 | $-396,357 | $629,723 |
| Revenues | $5,862,869 | $9,177,564 | $11,701,427 | $15,318,633 |
| InterestExpenseNonoperating | — | $23,734 | $17,601 | $15,852 |
| Nonoperating Income (Expense) | $-7,082 | $-105 | $-23,339 | $-24,059 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-267,300 | $33,426 | $-437,297 | $589,812 |
| Income Tax Expense (Benefit) | $3,294 | $7,305 | $5,606 | $38,879 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-270,594 | $26,121 | $-442,903 | $550,933 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $134 | $689 | $248 | $190 |
| Net Income (Loss) Attributable to Parent | $-270,728 | $25,432 | $-443,151 | $550,743 |
| Policyholder Benefits and Claims Incurred, Net | $4,642,024 | $7,332,589 | $10,019,025 | $12,230,703 |
| Selling, General and Administrative Expense | — | $1,755,565 | $2,049,867 | $2,429,937 |
| General and Administrative Expense | $339,716 | $32,145 | $28,892 | $28,270 |
| Benefits, Losses and Expenses | $6,098,484 | $9,120,299 | $12,097,784 | $14,688,910 |
| Weighted Average Number of Shares Outstanding, Basic | 221,655,493 | 240,386,000 | 262,388,000 | 309,168,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 221,655,493 | 265,853,000 | 262,388,000 | 323,436,000 |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | $-443,151 | $-443,151 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | — | 25,467,000 | 0 | -6,459,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Property, Plant and Equipment, Net | $61,930 | $66,793 | $88,350 | $101,494 |
| Debt Securities, Available-for-sale, Noncurrent | $365,309 | — | $1,470,987 | $1,600,770 |
| Restricted Cash and Investments, Noncurrent | $29,870 | $30,878 | $32,951 | $29,178 |
| Other Assets, Noncurrent | $83,271 | $82,397 | $119,719 | $122,134 |
| Assets | $3,601,480 | $4,840,496 | $6,325,411 | $11,226,762 |
| Long-term Debt, Excluding Current Maturities | $298,777 | $299,555 | $430,095 | $431,629 |
| Other Liabilities, Noncurrent | $67,574 | $61,282 | $51,994 | $50,466 |
| Liabilities | $2,795,363 | $3,824,071 | $5,344,676 | $9,171,597 |
| Cash and Cash Equivalents, at Carrying Value | $1,870,315 | $1,527,186 | $2,774,151 | $4,075,612 |
| Debt Securities, Available-for-sale, Current | $689,833 | — | $1,216,461 | $4,479,906 |
| Premiums and Other Receivables, Net | $201,269 | $315,891 | $442,645 | $442,645 |
| Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments | $241,194 | $291,537 | $99,750 | $196,544 |
| Other Assets, Current | $6,564 | $21,320 | $24,331 | $60,317 |
| Assets, Current | $3,061,100 | $2,845,174 | $4,613,404 | $9,373,186 |
| Liability for Claims and Claims Adjustment Expense | $965,986 | $1,356,730 | $1,455,385 | $1,898,435 |
| Unearned Premiums | $65,918 | $74,389 | $166,203 | $167,505 |
| Accounts Payable and Accrued Liabilities, Current | $273,367 | $432,428 | $649,720 | $525,709 |
| Reinsurance Payable | $61,024 | $41,346 | $3,579 | $2,564 |
| Liabilities, Current | $2,429,012 | $3,463,234 | $4,862,587 | $8,689,502 |
| Treasury Stock, Value | — | $2,923 | $2,923 | $2,923 |
| Additional Paid in Capital | $3,682,294 | $3,869,617 | $4,256,972 | $4,316,831 |
| Retained Earnings (Accumulated Deficit) | $-2,876,715 | $-2,851,283 | $-3,294,434 | $-2,253,630 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $1,309 | $-1,827 | $18,030 | $-8,250 |
| Stockholders' Equity Attributable to Parent | $803,967 | $1,013,586 | $977,648 | $2,052,031 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $2,150 | $2,839 | $3,087 | $3,134 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $806,117 | $1,016,425 | $980,735 | $2,055,165 |
| Treasury Stock, Common, Shares | 314,600 | 315,000 | 315,000 | 315,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-270,594 | $26,121 | $-442,903 | $550,933 |
| Net Cash Provided by (Used in) Operating Activities | $-272,159 | $978,193 | $1,094,854 | $4,418,570 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $311,474 | $-340,853 | $1,253,005 | $1,476,980 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,891,971 | $1,551,118 | $2,804,123 | $5,373,068 |
| Cash and Cash Equivalents, at Carrying Value | $1,870,315 | $1,527,186 | $2,774,151 | $5,342,735 |
| Restricted Cash and Cash Equivalents | $21,656 | $23,932 | $29,972 | $30,333 |
| Deferred Income Tax Expense (Benefit) | $58 | $-2,338 | $2,449 | $-5,282 |
| Payments to Acquire Debt Securities, Available-for-sale | $836,982 | $2,133,510 | $1,013,918 | $5,348,881 |
| Gain (Loss) on Sale of Investments | $-70 | $23 | $1,339 | $2,940 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $31,857 | $25,250 | $134,231 | $1,102,413 |
| Depreciation, Depletion and Amortization | $30,694 | $32,145 | $28,892 | $28,241 |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $1,410,166 | $744,794 | $670,724 | $957,248 |
| Amortization of Debt Issuance Costs | $778 | $778 | $1,630 | $3,404 |
| Payments to Acquire Productive Assets | $25,577 | $27,897 | $36,372 | $38,625 |
| Share-based Payment Arrangement, Noncash Expense | $159,683 | $109,824 | $87,654 | $75,193 |
| Increase (Decrease) of Restricted Investments | $2,277 | $-3,929 | $-4,275 | $-4,355 |
| Accretion (Amortization) of Discounts and Premiums, Investments | $29,374 | $26,877 | $29,793 | $29,411 |
| Net Cash Provided by (Used in) Investing Activities | $577,187 | $-1,387,434 | $-241,060 | $-3,323,490 |
| Provision for Other Credit Losses | $28,612 | $-300 | $-24,074 | $47,948 |
| Proceeds from Issuance of Long-term Debt | $0 | $0 | $410,000 | $410,000 |
| Payments of Debt Issuance Costs | $0 | $0 | $22,902 | $27,821 |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | $4,035 | $13,666 |
| Proceeds from Stock Options Exercised | $3,956 | $68,388 | $55,033 | $55,642 |
| Proceeds from Contributions from Affiliates | $2,490 | $0 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $6,446 | $68,388 | $399,211 | $381,900 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $23,156 | $33,691 | $12,783 | $7,423 |
| Income Taxes Paid, Net | $2,414 | $674 | $17,516 | $3,145 |
| Increase (Decrease) in Premiums Receivable | $13,405 | $114,323 | $101,932 | $101,932 |
| Increase (Decrease) in Reinsurance Recoverable | $-651,693 | $50,343 | $-191,787 | $3,846 |
| Increase (Decrease) in Other Operating Assets | $-11,307 | $11,547 | $27,116 | $27,264 |
| Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve | $28,258 | $390,744 | $98,655 | $346,803 |
| Increase (Decrease) in Unearned Premiums | $-13,080 | $8,472 | $91,814 | $98,016 |
| Increase (Decrease) in Future Policy Benefit Reserves | $1,562 | $-5,776 | $0 | $0 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $-29,180 | $152,768 | $205,488 | $84,288 |
| Increase (Decrease) in Reinsurance Payables | $-366,626 | $-19,678 | $-37,767 | $-10,817 |